DVA
DaVita Inc.
NYSE · USHealthcareMedical - Care Facilities
$234.10-1.21%
Price as of Jul 20, 2026
DVA financials
DaVita Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $13.6B | $12.8B | $12.1B | $11.6B |
| Cost of revenue | $10.0B | $8.6B | $8.3B | $8.2B |
| Gross profit | $3.7B | $4.2B | $3.8B | $3.4B |
| Operating expenses | $1.7B | $2.1B | $2.2B | $2.1B |
| Operating income | $2.0B | $2.1B | $1.6B | $1.3B |
| Net income | $746.8M | $936.3M | $691.5M | $560.4M |
| EBITDA | $2.6B | $2.7B | $2.3B | $2.1B |
| Basic EPS | $9.72 | $11.02 | $7.62 | $5.88 |
| Diluted EPS | $9.51 | $10.73 | $7.42 | $5.71 |
| Balance sheet | ||||
| Cash & equivalents | $757.7M | $794.9M | $380.1M | $244.1M |
| Total assets | $17.5B | $17.3B | $16.9B | $16.9B |
| Total liabilities | $16.3B | $15.2B | $14.2B | $14.7B |
| Stockholders’ equity | -$651.1M | $121.1M | $1.1B | $712.3M |
| Total debt | $15.0B | $12.1B | $11.1B | $11.8B |
| Net debt | $14.3B | $11.3B | $10.7B | $11.6B |
| Cash flow | ||||
| Operating cash flow | $1.9B | $2.0B | $2.1B | $1.6B |
| Capital expenditure | -$575.9M | -$555.4M | -$568.0M | -$603.4M |
| Free cash flow | $1.3B | $1.5B | $1.5B | $961.1M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | -$1.8B | -$1.4B | -$272.2M | -$802.2M |